{"id":"https://openalex.org/W1898569010","doi":"https://doi.org/10.1002/rcm.6639","title":"Addressing the need for biomarker liquid chromatography/mass spectrometry assays: A protocol for effective method development for the bioanalysis of endogenous compounds in cerebrospinal fluid","display_name":"Addressing the need for biomarker liquid chromatography/mass spectrometry assays: A protocol for effective method development for the bioanalysis of endogenous compounds in cerebrospinal fluid","publication_year":2013,"publication_date":"2013-07-09","ids":{"openalex":"https://openalex.org/W1898569010","doi":"https://doi.org/10.1002/rcm.6639","mag":"1898569010","pmid":"https://pubmed.ncbi.nlm.nih.gov/23857934"},"language":"en","primary_location":{"id":"doi:10.1002/rcm.6639","doi":"https://doi.org/10.1002/rcm.6639","is_oa":true,"landing_page_url":"https://doi.org/10.1002/rcm.6639","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/rcm.6639","source":{"id":"https://openalex.org/S89689683","display_name":"Rapid Communications in Mass Spectrometry","issn_l":"0951-4198","issn":["0951-4198","1097-0231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rapid Communications in Mass Spectrometry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/rcm.6639","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050774194","display_name":"Yulia Benitex","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yulia Benitex","raw_affiliation_strings":["Molecular Sciences and Candidate Optimization, Bioanalytical Research; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Sciences and Candidate Optimization, Bioanalytical Research; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077899342","display_name":"Colleen A. McNaney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen A. McNaney","raw_affiliation_strings":["Molecular Sciences and Candidate Optimization, Discovery Analytical Sciences; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Sciences and Candidate Optimization, Discovery Analytical Sciences; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022487398","display_name":"David Luchetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Luchetti","raw_affiliation_strings":["Discovery Medicine and Clinical Pharmacology Bristol\u2010Myers Squibb Company, Research & Development 5 Research Parkway Wallingford CT 06492 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Medicine and Clinical Pharmacology Bristol\u2010Myers Squibb Company, Research & Development 5 Research Parkway Wallingford CT 06492 USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060674227","display_name":"Eric Schaeffer","orcid":"https://orcid.org/0009-0008-3892-6163","observed_orcids":["https://orcid.org/0009-0008-3892-6163"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Schaeffer","raw_affiliation_strings":["Discovery Medicine and Clinical Pharmacology Bristol\u2010Myers Squibb Company, Research & Development 5 Research Parkway Wallingford CT 06492 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Medicine and Clinical Pharmacology Bristol\u2010Myers Squibb Company, Research & Development 5 Research Parkway Wallingford CT 06492 USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007190980","display_name":"Timothy V. Olah","orcid":"https://orcid.org/0000-0002-5973-2623","observed_orcids":["https://orcid.org/0000-0002-5973-2623"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy V. Olah","raw_affiliation_strings":["Molecular Sciences and Candidate Optimization, Bioanalytical Research; Bristol-Myers Squibb Company, Research & Development; Route 206 and Province Line Road; Lawrenceville; NJ; 08543; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Sciences and Candidate Optimization, Bioanalytical Research; Bristol-Myers Squibb Company, Research & Development; Route 206 and Province Line Road; Lawrenceville; NJ; 08543; USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060338827","display_name":"Daniel G. Morgan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel G. Morgan","raw_affiliation_strings":["Molecular Sciences and Candidate Optimization, Bioanalytical Research; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Sciences and Candidate Optimization, Bioanalytical Research; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039501181","display_name":"Dieter M. Drexler","orcid":"https://orcid.org/0000-0003-2877-7973","observed_orcids":["https://orcid.org/0000-0003-2877-7973"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dieter M. Drexler","raw_affiliation_strings":["Molecular Sciences and Candidate Optimization, Discovery Analytical Sciences; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Sciences and Candidate Optimization, Discovery Analytical Sciences; Bristol-Myers Squibb Company, Research & Development; 5 Research Parkway; Wallingford; CT; 06492; USA","institution_ids":["https://openalex.org/I4210091812"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5050774194"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":4840,"currency":"USD","value_usd":4840},"apc_paid":null,"fwci":0.5499,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.60088694,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"27","issue":"16","first_page":"1882","last_page":"1886"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.774399995803833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.774399995803833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10683","display_name":"Mass Spectrometry Techniques and Applications","score":0.07050000131130219,"subfield":{"id":"https://openalex.org/subfields/1607","display_name":"Spectroscopy"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.061400000005960464,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.972000002861023},{"id":"https://openalex.org/keywords/endogenous-neurotransmitters","display_name":"endogenous neurotransmitters","score":0.7950000166893005},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7200000286102295},{"id":"https://openalex.org/keywords/method-development","display_name":"method development","score":0.8259999752044678},{"id":"https://openalex.org/keywords/histamine","display_name":"histamine","score":0.8080000281333923},{"id":"https://openalex.org/keywords/histaminergic-system","display_name":"histaminergic system","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pre-column-derivatization","display_name":"pre-column derivatization","score":0.9610000252723694},{"id":"https://openalex.org/keywords/uplc-ms-ms","display_name":"UPLC-MS/MS","score":0.9309999942779541},{"id":"https://openalex.org/keywords/standard-addition-method","display_name":"standard addition","score":0.7139999866485596},{"id":"https://openalex.org/keywords/central-nervous-system-diseases","display_name":"central nervous system disorders","score":0.6830000281333923},{"id":"https://openalex.org/keywords/pharmacodynamic-markers","display_name":"pharmacodynamic biomarkers","score":0.8410000205039978}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8752341270446777},{"id":"https://openalex.org/C137535248","wikidata":"https://www.wikidata.org/wiki/Q4914691","display_name":"Bioanalysis","level":2,"score":0.7861051559448242},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.6504297256469727},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.621436357498169},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5566312074661255},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4712032973766327},{"id":"https://openalex.org/C10390740","wikidata":"https://www.wikidata.org/wiki/Q2282401","display_name":"Analyte","level":2,"score":0.4650968313217163},{"id":"https://openalex.org/C2776923573","wikidata":"https://www.wikidata.org/wiki/Q2294884","display_name":"Derivatization","level":3,"score":0.4349220395088196},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.32553941011428833},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.20213556289672852},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15135186910629272},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D006632","descriptor_name":"Histamine","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D008761","descriptor_name":"Methylhistamines","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D018494","descriptor_name":"Histamine Agents","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/rcm.6639","doi":"https://doi.org/10.1002/rcm.6639","is_oa":true,"landing_page_url":"https://doi.org/10.1002/rcm.6639","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/rcm.6639","source":{"id":"https://openalex.org/S89689683","display_name":"Rapid Communications in Mass Spectrometry","issn_l":"0951-4198","issn":["0951-4198","1097-0231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rapid Communications in Mass Spectrometry","raw_type":"journal-article"},{"id":"pmid:23857934","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23857934","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rapid communications in mass spectrometry : RCM","raw_type":"Evaluation Study"}],"best_oa_location":{"id":"doi:10.1002/rcm.6639","doi":"https://doi.org/10.1002/rcm.6639","is_oa":true,"landing_page_url":"https://doi.org/10.1002/rcm.6639","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/rcm.6639","source":{"id":"https://openalex.org/S89689683","display_name":"Rapid Communications in Mass Spectrometry","issn_l":"0951-4198","issn":["0951-4198","1097-0231"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rapid Communications in Mass Spectrometry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1898569010.pdf","grobid_xml":"https://content.openalex.org/works/W1898569010.grobid-xml"},"referenced_works_count":14,"referenced_works":["https://openalex.org/W52886305","https://openalex.org/W1519623007","https://openalex.org/W1976447614","https://openalex.org/W1977839424","https://openalex.org/W1994997661","https://openalex.org/W1995962430","https://openalex.org/W2009334465","https://openalex.org/W2012774682","https://openalex.org/W2074292769","https://openalex.org/W2079154608","https://openalex.org/W2079455913","https://openalex.org/W2117040869","https://openalex.org/W2140347699","https://openalex.org/W4413981450"],"related_works":["https://openalex.org/W4295008831","https://openalex.org/W4383677192","https://openalex.org/W2079154608","https://openalex.org/W2083554066","https://openalex.org/W1791050582","https://openalex.org/W4310817565","https://openalex.org/W4392303078","https://openalex.org/W2891147007","https://openalex.org/W4409528691","https://openalex.org/W3150665844"],"abstract_inverted_index":{"RATIONALE:":[0],"Research":[1],"on":[2],"disorders":[3],"of":[4,18,76,84,117,138,154,162,197,209],"the":[5,16,53,66,73,77,139,152,155,160,207],"central":[6],"nervous":[7],"system":[8,75,158],"(CNS)":[9],"has":[10,110],"shown":[11],"that":[12],"an":[13,199],"imbalance":[14],"in":[15,29,51,63,123,168,175],"levels":[17,31],"specific":[19,177],"endogenous":[20,105,121,200],"neurotransmitters":[21],"may":[22,32],"underlie":[23],"certain":[24],"CNS":[25],"diseases.":[26],"These":[27],"alterations":[28],"neurotransmitter":[30,157],"provide":[33],"insight":[34],"into":[35],"pathophysiology,":[36],"but":[37],"can":[38,88],"also":[39,195],"serve":[40],"as":[41,204],"disease":[42],"and":[43,70,79,100,127,136,144,159,164,178],"pharmacodynamic":[44],"biomarkers.":[45],"To":[46],"measure":[47],"these":[48,85],"potential":[49,86,101],"biomarkers":[50,87],"vivo,":[52],"relevant":[54],"sample":[55,95,134],"matrix":[56],"is":[57,62,194],"cerebrospinal":[58],"fluid":[59,69],"(CSF),":[60],"which":[61,193],"equilibrium":[64],"with":[65],"brain's":[67],"interstitial":[68],"circulates":[71],"through":[72],"ventricular":[74],"brain":[78],"spinal":[80],"cord.":[81],"Accurate":[82],"analysis":[83,161],"be":[89],"challenging":[90],"due":[91],"to":[92,132,151],"low":[93,97],"CSF":[94],"volume,":[96],"analyte":[98],"levels,":[99],"interferences":[102],"from":[103,206],"other":[104],"compounds.":[106],"METHODS:":[107],"A":[108],"protocol":[109,148,173],"been":[111],"established":[112],"for":[113,120],"effective":[114],"method":[115,181],"development":[116],"bioanalytical":[118],"assays":[119],"compounds":[122],"CSF.":[124,170],"Database":[125],"searches":[126],"standard-addition":[128],"experiments":[129],"are":[130],"employed":[131],"qualify":[133],"preparation":[135],"specificity":[137],"detection":[140],"thus":[141],"evaluating":[142],"accuracy":[143],"precision.":[145],"RESULTS:":[146],"This":[147],"was":[149],"applied":[150],"study":[153],"histaminergic":[156],"histamine":[163],"its":[165],"metabolite":[166],"1-methylhistamine":[167],"rat":[169],"CONCLUSIONS:":[171],"The":[172],"resulted":[174],"a":[176],"sensitive":[179],"novel":[180],"utilizing":[182],"pre-column":[183],"derivatization":[184],"ultra":[185],"high":[186],"performance":[187],"liquid":[188],"chromatography/tandem":[189],"mass":[190],"spectrometry":[191],"(UHPLC/MS/MS),":[192],"capable":[196],"separating":[198],"interfering":[201],"compound,":[202],"identified":[203],"taurine,":[205],"analytes":[208],"interest.":[210]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}